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Tuberculosis and HIV/AIDS have synergistic health impacts in terms of disease development and progression.
Therefore, collaborative TB and HIV/AIDS activities are a logical health systems response. However, the
establishment of these activities presents a challenge for countries that have strong vertical disease programs that
differ in their implementation philosophies. Here, we review the process by which TB/HIV collaboration was
established in Cambodia. A cycle of overlapping and mutually reinforcing initiatives – local research; piloted
implementation with multiple options; and several rounds of policy formulation guided by a cross-functional
Technical Working Group – was used to drive nationwide introduction of a full set of TB/HIV collaborative activities.
Senior Ministry of Health officials and partner organizations brought early attention to TB/HIV. Both national
programs implemented initial screening and testing interventions, even in the absence of a detailed, overarching
framework. The use of multiple options for HIV testing identified which programmatic options worked best, and
early implementation and pilots determined what unanswered questions required further research. Local conduct
of this research – on co-treatment timing and TB symptom screening – speeded adoption of the results into policy
guidance, and clarified the relative roles of the two programs. Roll-out is continuing, and results for a variety of key
indicators, including screening PLHIV for TB, and testing TB patients for HIV, are at 70-80% and climbing. This
experience in Cambodia illustrates the influence of health research on policy, and demonstrates that clear policy
guidance, the pursuit of incremental advances, and the use of different approaches to generate evidence can
overcome structural barriers to change and bring direct benefits to patients.
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Globally, tuberculosis (TB) and HIV/AIDS have proven
to be a deadly and mutually reinforcing combination. Per-
sons living with HIV (PLHIV) have 20–37 times greater
risk of developing TB [1]; as a result, increasing HIV
prevalence has led to a rapid rise in the number of TB
notifications [2]. In turn, TB contributes to ~20% of the
estimated deaths due to HIV infection [3].
Early efforts to address this threat were limited. Sub-
sequently, however, the necessary TB/HIV activities were
defined in the World Health Organization (WHO)’s 2004
interim policy [4] and accompanying guidelines [5]. Under
this policy, both the TB and HIV programs are respon-
sible for establishing the mechanisms for collaboration.* Correspondence: william.a.wells@gmail.com
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reproduction in any medium, provided the orThe HIV program is more responsible for the 3Is: inten-
sified case finding (ICF) of TB among PLHIV; isoniazid
preventive therapy (IPT) for PLHIV with latent TB [6];
and infection control (IC) [7]. Finally, the TB program is
more responsible for HIV testing and prevention among
TB patients and for connecting any coinfected patients
with HIV services. Although, on the surface, this descrip-
tion implies a clean division of labor, in practice there is
substantial overlap and cooperation required, and imple-
mentation approaches to achieve this have varied by
country [8].
Under the revised Global Plan to Stop TB [9], the key
TB/HIV targets (the percent of PLHIV screened for TB,
of TB patients tested for HIV, and of eligible people on
IPT, cotrimoxazole preventive therapy (CPT), and anti-
retroviral therapy (ART)) are all 100%. Still, however,
global achievements fall far short. In 2010, only 7% ofd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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their HIV status, 0.5% of PLHIV got IPT, and 77% and
46% of identified PLHIV with TB were started on CPT
and ART, respectively [3].
Based on an analysis of global and Cambodia-specific
literature, possible reasons for this incomplete imple-
mentation include the different cultures and parallel
structures of TB and HIV/AIDS national programs, and
remaining gaps in the evidence base. Here, we use these
two themes as a conceptual framework to review
Cambodia’s approach to establishing a TB/HIV collabor-
ation. Although roll-out is ongoing, we seek to docu-
ment and gain a better understanding of the process by
which a collaboration is built. This investigation reveals
the central role of research, in which successive waves of
health research have influenced health policy, implemen-
tation and, ultimately, patient outcomes.
Recognition of a problem
In Cambodia, TB control activities lapsed during the
1970s and into the 1980s, as conflict all but destroyed
the infrastructure and human resources needed for a
functioning health system. Although TB prevalence is
now declining, it remains high at 660 cases/100,000 pop-
ulation/year for 2010 [3]. HIV prevalence among these
TB patients is estimated at 6.3% compared to 0.8%
amongst the general adult population [10]. A concerted
effort to build a TB control system began only in 1993
[11]. Ten years later, Cambodia’s national HIV/AIDS
program began providing ART, which is now supplied
to 42,034 adults and 4,439 children (~78% of those in
need, with “need” defined as all those with CD4 less
than 350) [12].
Early HIV/AIDS teams in Cambodia documented and
acknowledged TB as the number one opportunistic in-
fection (OI) among PLHIV. Indeed, a coordinating body
for TB/HIV has existed for over a decade. But this body
has not always been active, and joint leadership was a
challenge. This is perhaps not surprising. The National
Center for HIV/AIDS, Dermatology and STDs (NCHADS)
and the National Centre for Tuberculosis and Leprosy
Control (CENAT) operate under different models that
are not a natural match: NCHADS relies on fewer, spe-
cialized centers (currently 56 OI/ART centers) and a mo-
bile system of home based care, whereas CENAT is more
decentralized in delivering services (via 1071 health facil-
ities (TB services), and a set of community DOTS work-
ers distinct from the home based care teams). Bridging
this organizational divide was never going to be easy. In
addition, relative to NCHADS, CENAT has fewer re-
sources [13], and both programs reflect the verticality
present in the international partner landscape.
This challenging scenario makes the recent progress
all the more interesting. There has not been a single, all-encompassing policy change; rather, progress has been
made via serial, smaller advancements from the TB and
HIV sides (Table 1), with each advance encouraging the
other program to act next.
Pilots, SOPs and evidence
Early on, the higher levels of the Ministry of Health and
global and external organizations drew attention to TB/
HIV, and there was critical support for action from the
leadership of both CENAT and NCHADS. Four TB/HIV
pilots established in Cambodia in 2003 [14] did not tran-
sition into joint national scale-up, but they did provide
experience and evidence for two advancements. First, in
2006 CENAT and NCHADS signed a standard operating
procedure (SOP) for HIV testing of TB patients and TB
screening of PLHIV [15]. Though brief, this SOP made
the valuable contribution of defining the core competen-
cies and commitments of each program; this was a road-
map for both the programs and for donors and partners.
It was clear that neither program could tackle the prob-
lem alone. Second, the pilots provided evidence on strat-
egies that worked (such as scripts and data collection
forms to encourage TB screening and HIV testing [16]
and cost effective approaches to ICF and IPT [17]) and
highlighted certain operational questions that needed
answering.
Some of these questions were tackled in trials con-
ducted in Cambodia. The CAMELIA (Cambodian Early
versus Late Introduction of Antiretroviral Drugs) trial
[18], building on the related South African trial [19], es-
tablished the need to start ART early in coinfected pa-
tients. This emphasized the importance of a unified,
coincident approach to treatment, rather than the se-
quential treatment that had been common. In addition,
the Improving Diagnosis of TB in HIV-Infected Persons
(ID-TB/HIV) study provided a simple protocol for
screening PLHIV in order to exclude TB [20], thus pav-
ing the way for provision of IPT. Half of the patients for
this study came from Cambodia, where the findings
were disseminated in 2009. Awareness of these two trials
and their results has driven incorporation of the latest
international evidence into national policies.
Options, incentives and experience
TB/HIV visibility and guidance was maintained via re-
gional conferences, frameworks [21] and linkages to
meetings that emphasized global normative standards.
Meanwhile, the conduct of individual TB/HIV activities
was providing experience and influencing policy devel-
opment. Screening of PLHIV for TB was ongoing, facili-
tated by the inclusion of a TB physician on most OI/
ART teams. For HIV testing of TB patients, CENAT
found that referral of blood was a far more efficient op-
tion than referral of patients or the use of mobile testing
Table 1 Timeline of TB/HIV activities in Cambodia*
Year Type^ Initiating agency Intervention Outcome Challenges
1993 I CENAT DOTS expansion
initiated
Availability of TB treatment increased Post-conflict environment
1999 P MoH TB/HIV subcommittee
formed
Dialogue initiated Irregular meetings; limited action
2002 P CENAT and NCHADS Framework for TB/HIV First formal agreement Agreement remained general; technical
direction still unclear




Availability of ART increased Initially low capacity of healthcare
system
2003 R NCHADS, CENAT,
WHO, FHI, US CDC,
JICA
TB/HIV pilot programs Pilots initiated and results published;
operational challenges highlighted
Commitment to national roll-out not
present prior to pilots, and relative
roles of CENAT and NCHADS were not
yet defined
2006 P CENAT and NCHADS SoP on HIV testing of
TB patients and TB
screening of PLHIV
Relative roles of CENAT and NCHADS
defined; OI/ART teams screened PLHIV for
TB and CENAT used 3 options to increase
screening of TB patients for HIV
Technical questions remained, i.e.,
research was needed to define best
practices for ART initiation and TB
symptom screening prior to IPT








Results define when ART should be
started in TB patients and what symptom
screen to use in PLHIV prior to IPT
Very few challenges; rapid adoption of
findings into field practice
2010 P TWG for TB/HIV,
NCHADS with CENAT
3Is SOP completed Roll-out of 3Is, based on detailed roles
and responsibilities
TB screening of existing PLHIV may put
burden on TB diagnostic services
2010 P CENAT, NCHADS Revised TB/HIV
framework
All TB/HIV policy captured in a single
document
*Abbreviations not defined in main text: MoH (Ministry of Health); FHI (Family Health International); US CDC (US Centers for Disease Control); JICA (Japan International
Cooperation Agency); TWG (Technical Working Group).
^Types of activities are research (R), policy (P), and implementation (I).
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boosted testing rates even further, from ~50% to ~90%,
depending on the province, and TB services used their
repeat encounters with patients to talk about the im-
portance of testing. These and related CENAT activities
were acknowledged by NCHADS as bringing HIV ser-
vices to health centers, and thus closer to clients. Fur-
thermore, these experiences made development of the
more comprehensive SOPs and frameworks both less
threatening – because experience had already clarified
which activity was being undertaken by which program –
and more practical.
Formulation of the SOP for the 3Is was coordinated
by the Technical Working Group for TB/HIV, which
brought together opinions from NCHADS, CENAT and
partners, monitored progress, and maintained pressure
for action. This completed SOP [22] includes precise and
practical details on relative responsibilities (e.g., CENAT
procures isoniazid for NCHADS to carry out IPT), al-
though challenges remain for areas with less clear guid-
ance (e.g., certain recording and reporting activities, and
the diagnostic workup of PLHIV who are positive for the
TB suspect symptom screen). The revision of the overall
TB/HIV framework [23] reflects the new 3Is SOP, which
by 2013 will be implemented nationwide.Outcomes
In terms of policy, evidence, and experience, the critical
building blocks for TB/HIV collaboration in Cambodia
are now in place. Financing for TB/HIV activities is also
available and allowing for rapid rollout; of note, the Glo-
bal Fund grant process has, in effect, provided a forum
for joint planning.
The timing of roll-out, and thus the outcomes of im-
plementation thus far, varies between the different activ-
ities. TB screening of existing OI/ART clients only
became a policy in 2010, and is being introduced along
with the new symptom-based screening, but already 87%
of newly registered OI/ART clients were screened for TB
in early 2011. At TB services, HIV testing of TB patients
has been in place for several years, so in 2011 82% of no-
tified TB patients had a known HIV test result [24].
With roll-out of the 3Is SOP, 85.5% of coinfected indivi-
duals were confirmed as started on CPT and 78% on
ART [24]; these numbers built upon a doubling and trip-
ling from 2009 to 2010 due largely to improvements in
reporting. Finally, from 2009 to 2011 the provision of
IPT has expanded significantly (from a coverage of 66
PLHIV without TB in 2009 to 645 in 2011), and should
continue to rise with the 3Is roll-out and new screening
algorithm.
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Cambodia’s path to TB/HIV implementation has not
been easy. Consistent with the framework for this article,
there have been challenges in overcoming the separation
between the TB and HIV programs to address the first
step – the establishment of a politically powerful and
active mechanism for coordination, which requires the
cooperation of both programs. A major cause of these
challenges appears to have been the early gaps in the
evidence base and thus incomplete technical guidance.
But the country’s progress illustrates that these chal-
lenges need not prevent progress. Instead, the conduct
of critical research and the gradual definition of each
program’s activities can lead, eventually, to greater trust,
a better understanding of how the different implementa-
tion approaches driving the TB and HIV/AIDS national
programs can complement each other, and a more com-
prehensive response to the TB/HIV challenge. Two pro-
grams, strong individually, have built upon each other’s
advances, and the processes of policy, practice and re-
search have reinforced each other to keep the TB/HIV
agenda moving. In providing this example, Cambodia’s
TB/HIV activities will, if done well, have an impact well
beyond the country’s borders.
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